Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1988 Oct 15;255(2):377–390. doi: 10.1042/bj2550377

Peptides from the calcitonin genes: molecular genetics, structure and function.

L H Breimer 1, I MacIntyre 1, M Zaidi 1
PMCID: PMC1135239  PMID: 3060108

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aer J. Effect of thyrocalcitonin on urinary hydroxyproline and calcium in rats. Endocrinology. 1968 Aug;83(2):379–380. doi: 10.1210/endo-83-2-379. [DOI] [PubMed] [Google Scholar]
  2. Agus Z. S., Wasserstein A., Goldfarb S. PTH, calcitonin, cyclic nucleotides and the kidney. Annu Rev Physiol. 1981;43:583–595. doi: 10.1146/annurev.ph.43.030181.003055. [DOI] [PubMed] [Google Scholar]
  3. Alevizaki M., Shiraishi A., Rassool F. V., Ferrier G. J., MacIntyre I., Legon S. The calcitonin-like sequence of the beta CGRP gene. FEBS Lett. 1986 Sep 29;206(1):47–52. doi: 10.1016/0014-5793(86)81338-2. [DOI] [PubMed] [Google Scholar]
  4. Aliapoulios M. A., Goldhaber P., Munson P. L. Thyrocalcitonin inhibition of bone resorption induced by parathyroid hormone in tissue culture. Science. 1966 Jan 21;151(3708):330–331. doi: 10.1126/science.151.3708.330. [DOI] [PubMed] [Google Scholar]
  5. Allan E. Calcitonin in the treatment of intractable pain from advanced malignancy. Pharmatherapeutica. 1983;3(7):482–486. [PubMed] [Google Scholar]
  6. Allison J., Hall L., MacIntyre I., Craig R. K. The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein. Biochem J. 1981 Dec 1;199(3):725–731. doi: 10.1042/bj1990725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Amara S. G., Arriza J. L., Leff S. E., Swanson L. W., Evans R. M., Rosenfeld M. G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science. 1985 Sep 13;229(4718):1094–1097. doi: 10.1126/science.2994212. [DOI] [PubMed] [Google Scholar]
  8. Amara S. G., David D. N., Rosenfeld M. G., Roos B. A., Evans R. M. Characterization of rat calcitonin mRNA. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4444–4448. doi: 10.1073/pnas.77.8.4444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Amara S. G., Evans R. M., Rosenfeld M. G. Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol Cell Biol. 1984 Oct;4(10):2151–2160. doi: 10.1128/mcb.4.10.2151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Amara S. G., Jonas V., Rosenfeld M. G., Ong E. S., Evans R. M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982 Jul 15;298(5871):240–244. doi: 10.1038/298240a0. [DOI] [PubMed] [Google Scholar]
  11. BAGHDIANTZ A., FOSTER G. V., EDWARDS A., KUMAR M. A., SLACK E., SOLIMAN H. A., MACINTYRE I. EXTRACTION AND PURIFICATION OF CALCITONIN. Nature. 1964 Sep 5;203:1027–1028. doi: 10.1038/2031027a0. [DOI] [PubMed] [Google Scholar]
  12. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
  13. Baylin S. B., Höppener J. W., de Bustros A., Steenbergh P. H., Lips C. J., Nelkin B. D. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res. 1986 Jun;46(6):2917–2922. [PubMed] [Google Scholar]
  14. Bindereif A., Green M. R. An ordered pathway of snRNP binding during mammalian pre-mRNA splicing complex assembly. EMBO J. 1987 Aug;6(8):2415–2424. doi: 10.1002/j.1460-2075.1987.tb02520.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Birnbaum R. S., O'Neil J. A., Muszynski M., Aron D. C., Roos B. A. A non-calcitonin secretory peptide derived from preprocalcitonin. J Biol Chem. 1982 Jan 10;257(1):241–244. [PubMed] [Google Scholar]
  16. Bohmann D., Bos T. J., Admon A., Nishimura T., Vogt P. K., Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science. 1987 Dec 4;238(4832):1386–1392. doi: 10.1126/science.2825349. [DOI] [PubMed] [Google Scholar]
  17. Bovenberg R. A., van de Meerendonk W. P., Baas P. D., Steenbergh P. H., Lips C. J., Jansz H. S. Model for alternative RNA processing in human calcitonin gene expression. Nucleic Acids Res. 1986 Nov 25;14(22):8785–8803. doi: 10.1093/nar/14.22.8785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bradbury A. F., Finnie M. D., Smyth D. G. Mechanism of C-terminal amide formation by pituitary enzymes. Nature. 1982 Aug 12;298(5875):686–688. doi: 10.1038/298686a0. [DOI] [PubMed] [Google Scholar]
  19. Braga P., Ferri S., Santagostino A., Olgiati V. R., Pecile A. Lack of opiate receptor involvement in centrally induced calcitonin analgesia. Life Sci. 1978 Mar;22(11):971–977. doi: 10.1016/0024-3205(78)90362-4. [DOI] [PubMed] [Google Scholar]
  20. Brain S. D., MacIntyre I., Williams T. J. A second form of human calcitonin gene-related peptide which is a potent vasodilator. Eur J Pharmacol. 1986 May 27;124(3):349–352. doi: 10.1016/0014-2999(86)90238-4. [DOI] [PubMed] [Google Scholar]
  21. Brain S. D., Williams T. J. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol. 1985 Dec;86(4):855–860. doi: 10.1111/j.1476-5381.1985.tb11107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985 Jan 3;313(5997):54–56. doi: 10.1038/313054a0. [DOI] [PubMed] [Google Scholar]
  23. Breitbart R. E., Andreadis A., Nadal-Ginard B. Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu Rev Biochem. 1987;56:467–495. doi: 10.1146/annurev.bi.56.070187.002343. [DOI] [PubMed] [Google Scholar]
  24. Brewer H. B., Jr, Ronan R. Amino acid sequence of bovine thyrocalcitonin. Proc Natl Acad Sci U S A. 1969 Jul;63(3):940–947. doi: 10.1073/pnas.63.3.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Byfield P. G., Clark M. B., Turner K., Foster G. V., MacIntyre I. Immunochemical studies on human calcitonin M leading to information on the shape of the molecule. Biochem J. 1972 Mar;127(1):199–206. doi: 10.1042/bj1270199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Byfield P. G., Matthews E. W., Heersche J. N., Boorman G. A., Girgis S. I., Macintyre I. Isolation of calcitonin from rat thyroid medullary carcinoma. FEBS Lett. 1976 Jun 1;65(2):238–241. doi: 10.1016/0014-5793(76)80488-7. [DOI] [PubMed] [Google Scholar]
  27. Byfield P. G., McLoughlin J. L., Matthews E. W., MacIntyre I. A proposed structure for rat calcitonin. FEBS Lett. 1976 Jun 1;65(2):242–245. doi: 10.1016/0014-5793(76)80489-9. [DOI] [PubMed] [Google Scholar]
  28. COPP D. H., CHENEY B. Calcitonin-a hormone from the parathyroid which lowers the calcium-level of the blood. Nature. 1962 Jan 27;193:381–382. doi: 10.1038/193381a0. [DOI] [PubMed] [Google Scholar]
  29. Ceserani R., Colombo M., Olgiati V. R., Pecile A. Calcitonin and prostaglandin system. Life Sci. 1979 Nov 19;25(21):1851–1855. doi: 10.1016/0024-3205(79)90433-8. [DOI] [PubMed] [Google Scholar]
  30. Chambers T. J., Ali N. N. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1. J Pathol. 1983 Mar;139(3):383–397. doi: 10.1002/path.1711390313. [DOI] [PubMed] [Google Scholar]
  31. Chambers T. J., Fuller K., McSheehy P. M., Pringle J. A. The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. J Pathol. 1985 Apr;145(4):297–305. doi: 10.1002/path.1711450403. [DOI] [PubMed] [Google Scholar]
  32. Chambers T. J., Magnus C. J. Calcitonin alters behaviour of isolated osteoclasts. J Pathol. 1982 Jan;136(1):27–39. doi: 10.1002/path.1711360104. [DOI] [PubMed] [Google Scholar]
  33. Chambers T. J., McSheehy P. M., Thomson B. M., Fuller K. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 1985 Jan;116(1):234–239. doi: 10.1210/endo-116-1-234. [DOI] [PubMed] [Google Scholar]
  34. Chambers T. J., Moore A. The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab. 1983 Oct;57(4):819–824. doi: 10.1210/jcem-57-4-819. [DOI] [PubMed] [Google Scholar]
  35. Chambers T. J. Osteoblasts release osteoclasts from calcitonin-induced quiescence. J Cell Sci. 1982 Oct;57:247–260. doi: 10.1242/jcs.57.1.247. [DOI] [PubMed] [Google Scholar]
  36. Chambers T. J., Revell P. A., Fuller K., Athanasou N. A. Resorption of bone by isolated rabbit osteoclasts. J Cell Sci. 1984 Mar;66:383–399. doi: 10.1242/jcs.66.1.383. [DOI] [PubMed] [Google Scholar]
  37. Chambers T. J. The pathobiology of the osteoclast. J Clin Pathol. 1985 Mar;38(3):241–252. doi: 10.1136/jcp.38.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chausmer A. B., Stevens M. D., Severn C. Autoradiographic evidence for a calcitonin receptor on testicular Leydig cells. Science. 1982 May 14;216(4547):735–736. doi: 10.1126/science.6281881. [DOI] [PubMed] [Google Scholar]
  39. Chiu K. C., Smith R. A. Covalent linkage of phosphoinositides to myelin basic protein: in vitro incorporation of [32P] phosphoinositides to myelin basic protein. Biochem Biophys Res Commun. 1987 Jun 15;145(2):803–809. doi: 10.1016/0006-291x(87)91036-9. [DOI] [PubMed] [Google Scholar]
  40. Chiu R., Imagawa M., Imbra R. J., Bockoven J. R., Karin M. Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature. 1987 Oct 15;329(6140):648–651. doi: 10.1038/329648a0. [DOI] [PubMed] [Google Scholar]
  41. Clementi G., Amico-Roxas M., Rapisarda E., Caruso A., Prato A., Trombadore S., Priolo G., Scapagnini U. The analgesic activity of calcitonin and the central serotonergic system. Eur J Pharmacol. 1985 Jan 15;108(1):71–75. doi: 10.1016/0014-2999(85)90284-5. [DOI] [PubMed] [Google Scholar]
  42. Clementi G., Nicoletti F., Patacchioli F., Prato A., Patti F., Fiore C. E., Matera M., Scapagnini U. Hypoprolactinemic action of calcitonin and the tuberoinfundibular dopaminergic system. J Neurochem. 1983 Mar;40(3):885–886. doi: 10.1111/j.1471-4159.1983.tb08063.x. [DOI] [PubMed] [Google Scholar]
  43. Cooper C. W., Schwesinger W. H., Mahgoub A. M., Ontjes D. A. Thyrocalcitonin: stimulation of secretion by pentagastrin. Science. 1971 Jun 18;172(3989):1238–1240. doi: 10.1126/science.172.3989.1238. [DOI] [PubMed] [Google Scholar]
  44. Craig R. K., Hall L., Edbrooke M. R., Allison J., MacIntyre I. Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides. Nature. 1982 Jan 28;295(5847):345–347. doi: 10.1038/295345a0. [DOI] [PubMed] [Google Scholar]
  45. Crenshaw E. B., 3rd, Russo A. F., Swanson L. W., Rosenfeld M. G. Neuron-specific alternative RNA processing in transgenic mice expressing a metallothionein-calcitonin fusion gene. Cell. 1987 May 8;49(3):389–398. doi: 10.1016/0092-8674(87)90291-1. [DOI] [PubMed] [Google Scholar]
  46. D'Souza S. M., MacIntyre I., Girgis S. I., Mundy G. R. Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro. Endocrinology. 1986 Jul;119(1):58–61. doi: 10.1210/endo-119-1-58. [DOI] [PubMed] [Google Scholar]
  47. Diez Guerra F. J., Zaidi M., Bevis P., MacIntyre I., Emson P. C. Evidence for release of calcitonin gene-related peptide and neurokinin A from sensory nerve endings in vivo. Neuroscience. 1988 Jun;25(3):839–846. doi: 10.1016/0306-4522(88)90039-5. [DOI] [PubMed] [Google Scholar]
  48. Douglass J., Civelli O., Herbert E. Polyprotein gene expression: generation of diversity of neuroendocrine peptides. Annu Rev Biochem. 1984;53:665–715. doi: 10.1146/annurev.bi.53.070184.003313. [DOI] [PubMed] [Google Scholar]
  49. Dunn G. A., Brown A. F. Alignment of fibroblasts on grooved surfaces described by a simple geometric transformation. J Cell Sci. 1986 Jul;83:313–340. doi: 10.1242/jcs.83.1.313. [DOI] [PubMed] [Google Scholar]
  50. Elalouf J. M., Roinel N., de Rouffignac C. Stimulation by human calcitonin of electrolyte transport in distal tubules of rat kidney. Pflugers Arch. 1983 Oct;399(2):111–118. doi: 10.1007/BF00663905. [DOI] [PubMed] [Google Scholar]
  51. Epand R. M., Epand R. F., Orlowski R. C., Flanigan E., Stahl G. L. A comparison of the interaction of glucagon, human parathyroid hormone-(1-34)-peptide and calcitonin with dimyristoylphosphatidylglycerol and with dimyristoylphosphatidylcholine. Biophys Chem. 1985 Nov;23(1-2):39–48. doi: 10.1016/0301-4622(85)80062-4. [DOI] [PubMed] [Google Scholar]
  52. Epand R. M., Epand R. F., Orlowski R. C., Seyler J. K., Colescott R. L. Conformational flexibility and biological activity of salmon calcitonin. Biochemistry. 1986 Apr 22;25(8):1964–1968. doi: 10.1021/bi00356a019. [DOI] [PubMed] [Google Scholar]
  53. FOSTER G. V., BAGHDIANTZ A., KUMAR M. A., SLACK E., SOLIMAN H. A., MACINTYRE I. THYROID ORIGIN OF CALCITONIN. Nature. 1964 Jun 27;202:1303–1305. doi: 10.1038/2021303a0. [DOI] [PubMed] [Google Scholar]
  54. Findlay D. M., Michelangeli V. P., Eisman J. A., Frampton R. J., Moseley J. M., MacIntyre I., Whitehead R., Martin T. J. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Cancer Res. 1980 Dec;40(12):4764–4767. [PubMed] [Google Scholar]
  55. Findlay D. M., Michelangeli V. P., Moseley J. M., Martin T. J. Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D). Biochem J. 1981 May 15;196(2):513–520. doi: 10.1042/bj1960513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Findlay D. M., Michelangeli V. P., Orlowski R. C., Martin T. J. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin. Endocrinology. 1983 Apr;112(4):1288–1291. doi: 10.1210/endo-112-4-1288. [DOI] [PubMed] [Google Scholar]
  57. Findlay D. M., Ng K. W., Niall M., Martin T. J. Processing of calcitonin and epidermal growth factor after binding to receptors in human breast cancer cells (T 47D). Biochem J. 1982 Aug 15;206(2):343–350. doi: 10.1042/bj2060343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Findlay D. M., deLuise M., Michelangeli V. P., Ellison M., Martin T. J. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line. Cancer Res. 1980 Apr;40(4):1311–1317. [PubMed] [Google Scholar]
  59. Findlay D. M., deLuise M., Michelangeli V. P., Martin T. J. Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line. J Endocrinol. 1981 Feb;88(2):271–281. doi: 10.1677/joe.0.0880271. [DOI] [PubMed] [Google Scholar]
  60. Fisher L. A., Kikkawa D. O., Rivier J. E., Amara S. G., Evans R. M., Rosenfeld M. G., Vale W. W., Brown M. R. Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature. 1983 Oct 6;305(5934):534–536. doi: 10.1038/305534a0. [DOI] [PubMed] [Google Scholar]
  61. Fontaine B., Klarsfeld A., Hökfelt T., Changeux J. P. Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci Lett. 1986 Oct 30;71(1):59–65. doi: 10.1016/0304-3940(86)90257-0. [DOI] [PubMed] [Google Scholar]
  62. Forbes D. J., Kirschner M. W., Caput D., Dahlberg J. E., Lund E. Differential expression of multiple U1 small nuclear RNAs in oocytes and embryos of Xenopus laevis. Cell. 1984 Oct;38(3):681–689. doi: 10.1016/0092-8674(84)90263-0. [DOI] [PubMed] [Google Scholar]
  63. Foreman J. C., Jordan C. C., Oehme P., Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol. 1983 Feb;335:449–465. doi: 10.1113/jphysiol.1983.sp014543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Fouchereau-Peron M., Moukhtar M. S., Benson A. A., Milhaud G. Characterization of specific receptors for calcitonin in porcine lung. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3973–3975. doi: 10.1073/pnas.78.6.3973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Fraioli F., Fabbri A., Gnessi L., Moretti C., Santoro C., Felici M. Subarachnoid injection of salmon calcitonin induces analgesia in man. Eur J Pharmacol. 1982 Mar 12;78(3):381–382. doi: 10.1016/0014-2999(82)90044-9. [DOI] [PubMed] [Google Scholar]
  66. Freake H. C., MacIntyre I. Specific binding of 1,25-dihydroxycholecalciferol in human medullary thyroid carcinoma. Biochem J. 1982 Jul 15;206(1):181–184. doi: 10.1042/bj2060181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Fried M., Crothers D. M. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 1981 Dec 11;9(23):6505–6525. doi: 10.1093/nar/9.23.6505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Friedman J., Raisz L. G. Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science. 1965 Dec 10;150(3702):1465–1467. doi: 10.1126/science.150.3702.1465. [DOI] [PubMed] [Google Scholar]
  69. Galas D. J., Schmitz A. DNAse footprinting: a simple method for the detection of protein-DNA binding specificity. Nucleic Acids Res. 1978 Sep;5(9):3157–3170. doi: 10.1093/nar/5.9.3157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Gamse R., Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol. 1985 Aug 7;114(1):61–66. doi: 10.1016/0014-2999(85)90520-5. [DOI] [PubMed] [Google Scholar]
  71. Gennari C., Fischer J. A. Cardiovascular action of calcitonin gene-related peptide in humans. Calcif Tissue Int. 1985 Dec;37(6):581–584. doi: 10.1007/BF02554909. [DOI] [PubMed] [Google Scholar]
  72. Glowacki J., O'Sullivan J., Miller M., Wilkie D. W., Deftos L. J. Calcitonin produces hypercalcemia in leopard sharks. Endocrinology. 1985 Feb;116(2):827–829. doi: 10.1210/endo-116-2-827. [DOI] [PubMed] [Google Scholar]
  73. Goldring S. R., Dayer J. M., Ausiello D. A., Krane S. M. A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressin. Biochem Biophys Res Commun. 1978 Jul 28;83(2):434–440. doi: 10.1016/0006-291x(78)91009-4. [DOI] [PubMed] [Google Scholar]
  74. Goltzman D., Mitchell J. Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science. 1985 Mar 15;227(4692):1343–1345. doi: 10.1126/science.2983422. [DOI] [PubMed] [Google Scholar]
  75. Goodman R. H., Jacobs J. W., Habener J. F. Cell-free translation of messenger RNA coding for a precursor of human calcitonin. Biochem Biophys Res Commun. 1979 Dec 14;91(3):932–938. doi: 10.1016/0006-291x(79)91969-7. [DOI] [PubMed] [Google Scholar]
  76. Gurney A. M., Lester H. A. Light-flash physiology with synthetic photosensitive compounds. Physiol Rev. 1987 Apr;67(2):583–617. doi: 10.1152/physrev.1987.67.2.583. [DOI] [PubMed] [Google Scholar]
  77. Haas H. G., Dambacher M. A., Guncaga J., Lauffenbruger T. Renal effects of calcitonin and parathyroid extract in man. Studies in hypoparathyroidism. J Clin Invest. 1971 Dec;50(12):2689–2702. doi: 10.1172/JCI106770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Habener J. F., Singer F. R., Deftos L. J., Neer R. M., Potts J. T., Jr Explanation for unusual potency of salmon calcitonin. Nat New Biol. 1971 Jul 21;232(29):91–92. doi: 10.1038/newbio232091a0. [DOI] [PubMed] [Google Scholar]
  79. Haller-Brem S., Muff R., Petermann J. B., Born W., Roos B. A., Fischer J. A. Role of cytosolic free calcium concentration in the secretion of calcitonin gene-related peptide and calcitonin from medullary thyroid carcinoma cells. Endocrinology. 1987 Oct;121(4):1272–1277. doi: 10.1210/endo-121-4-1272. [DOI] [PubMed] [Google Scholar]
  80. Heersche J. N., Marcus R., Aurbach G. D. Calcitonin and the formation of 3',5'-AMP in bone and kidney. Endocrinology. 1974 Jan;94(1):241–247. doi: 10.1210/endo-94-1-241. [DOI] [PubMed] [Google Scholar]
  81. Holman J. J., Craig R. K., Marshall I. Human alpha- and beta-CGRP and rat alpha-CGRP are coronary vasodilators in the rat. Peptides. 1986 Mar-Apr;7(2):231–235. doi: 10.1016/0196-9781(86)90218-4. [DOI] [PubMed] [Google Scholar]
  82. Holtrop M. E., Raisz L. G., Simmons H. A. The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol. 1974 Feb;60(2):346–355. doi: 10.1083/jcb.60.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Horiuchi N., Takahashi H., Matsumoto T., Takahashi N., Shimazawa E., Suda T., Ogata E. Salmon calcitonin-induced stimulation of 1 alpha,25-dihydroxycholecalciferol synthesis in rats involving a mechanism independent of adenosine 3':5'-cyclic monophosphate. Biochem J. 1979 Nov 15;184(2):269–275. doi: 10.1042/bj1840269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Hunt N. H., Ellison M., Underwood J. C., Martin T. J. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line. Br J Cancer. 1977 Jun;35(6):777–784. doi: 10.1038/bjc.1977.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Höppener J. W., Steenbergh P. H., Zandberg J., Geurts van Kessel A. H., Baylin S. B., Nelkin B. D., Jansz H. S., Lips C. J. The second human calcitonin/CGRP gene is located on chromosome 11. Hum Genet. 1985;70(3):259–263. doi: 10.1007/BF00273453. [DOI] [PubMed] [Google Scholar]
  86. Ito M. B., Schraer H., Gay C. V. The effects of calcitonin, parathyroid hormone and prostaglandin E2 on cyclic AMP levels of isolated osteoclasts. Comp Biochem Physiol A Comp Physiol. 1985;81(3):653–657. doi: 10.1016/0300-9629(85)91043-6. [DOI] [PubMed] [Google Scholar]
  87. Jacobs J. W., Lund P. K., Potts J. T., Jr, Bell N. H., Habener J. F. Procalcitonin is a glycoprotein. J Biol Chem. 1981 Mar 25;256(6):2803–2807. [PubMed] [Google Scholar]
  88. Jacobs J. W., Potts J. T., Jr, Bell N. H., Habener J. F. Calcitonin precursor identified by cell-free translation of mRNA. J Biol Chem. 1979 Nov 10;254(21):10600–10603. [PubMed] [Google Scholar]
  89. Jonas V., Lin C. R., Kawashima E., Semon D., Swanson L. W., Mermod J. J., Evans R. M., Rosenfeld M. G. Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression. Proc Natl Acad Sci U S A. 1985 Apr;82(7):1994–1998. doi: 10.1073/pnas.82.7.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Jung A., Sippel A. E., Grez M., Schütz G. Exons encode functional and structural units of chicken lysozyme. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5759–5763. doi: 10.1073/pnas.77.10.5759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. KUMAR M. A., FOSTER G. V., MACINTYRE I. FURTHER EVIDENCE FOR CALCITONIN. A RAPID-ACTING HORMONE WHICH LOWERS PLASMA-CALCIUM. Lancet. 1963 Sep 7;2(7306):480–482. doi: 10.1016/s0140-6736(63)90224-1. [DOI] [PubMed] [Google Scholar]
  92. Kadonaga J. T., Tjian R. Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci U S A. 1986 Aug;83(16):5889–5893. doi: 10.1073/pnas.83.16.5889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Kaiser E. T., Kézdy F. J. Amphiphilic secondary structure: design of peptide hormones. Science. 1984 Jan 20;223(4633):249–255. doi: 10.1126/science.6322295. [DOI] [PubMed] [Google Scholar]
  94. Kallio D. M., Garant P. R., Minkin C. Ultrastructural effects of calcitonin on osteoclasts in tissue culture. J Ultrastruct Res. 1972 May;39(3):205–216. doi: 10.1016/s0022-5320(72)90017-2. [DOI] [PubMed] [Google Scholar]
  95. Kawai Y., Takami K., Shiosaka S., Emson P. C., Hillyard C. J., Girgis S., MacIntyre I., Tohyama M. Topographic localization of calcitonin gene-related peptide in the rat brain: an immunohistochemical analysis. Neuroscience. 1985 Jul;15(3):747–763. doi: 10.1016/0306-4522(85)90076-4. [DOI] [PubMed] [Google Scholar]
  96. Kawashima H., Torikai S., Kurokawa K. Calcitonin selectively stimulates 25-hydroxyvitamin D3-1 alpha-hydroxylase in proximal straight tubule of rat kidney. Nature. 1981 May 28;291(5813):327–329. doi: 10.1038/291327a0. [DOI] [PubMed] [Google Scholar]
  97. Kawashima H., Torikai S., Kurokawa K. Localization of 25-hydroxyvitamin D3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron. Proc Natl Acad Sci U S A. 1981 Feb;78(2):1199–1203. doi: 10.1073/pnas.78.2.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Kittur S. D., Hoppener J. W., Antonarakis S. E., Daniels J. D., Meyers D. A., Maestri N. E., Jansen M., Korneluk R. G., Nelkin B. D., Kazazian H. H., Jr Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5064–5067. doi: 10.1073/pnas.82.15.5064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Konarska M. M., Sharp P. A. Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs. Cell. 1986 Sep 12;46(6):845–855. doi: 10.1016/0092-8674(86)90066-8. [DOI] [PubMed] [Google Scholar]
  100. Krahn D. D., Gosnell B. A., Levine A. S., Morley J. E. Effects of calcitonin gene-related peptide on food intake. Peptides. 1984 Sep-Oct;5(5):861–864. doi: 10.1016/0196-9781(84)90107-4. [DOI] [PubMed] [Google Scholar]
  101. Kubota M., Moseley J. M., Butera L., Dusting G. J., MacDonald P. S., Martin T. J. Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1985 Oct 15;132(1):88–94. doi: 10.1016/0006-291x(85)90992-1. [DOI] [PubMed] [Google Scholar]
  102. Lacal J. C., Santos E., Notario V., Barbacid M., Yamazaki S., Kung H., Seamans C., McAndrew S., Crowl R. Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5305–5309. doi: 10.1073/pnas.81.17.5305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Lamp S. J., Findlay D. M., Moseley J. M., Martin T. J. Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D). J Biol Chem. 1981 Dec 10;256(23):12269–12274. [PubMed] [Google Scholar]
  104. Land H., Schütz G., Schmale H., Richter D. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature. 1982 Jan 28;295(5847):299–303. doi: 10.1038/295299a0. [DOI] [PubMed] [Google Scholar]
  105. Lasmoles F., Jullienne A., Day F., Minvielle S., Milhaud G., Moukhtar M. S. Elucidation of the nucleotide sequence of chicken calcitonin mRNA: direct evidence for the expression of a lower vertebrate calcitonin-like gene in man and rat. EMBO J. 1985 Oct;4(10):2603–2607. doi: 10.1002/j.1460-2075.1985.tb03977.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Laufer R., Changeux J. P. Calcitonin gene-related peptide elevates cyclic AMP levels in chick skeletal muscle: possible neurotrophic role for a coexisting neuronal messenger. EMBO J. 1987 Apr;6(4):901–906. doi: 10.1002/j.1460-2075.1987.tb04836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Lee Y., Takami K., Kawai Y., Girgis S., Hillyard C. J., MacIntyre I., Emson P. C., Tohyama M. Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience. 1985 Aug;15(4):1227–1237. doi: 10.1016/0306-4522(85)90265-9. [DOI] [PubMed] [Google Scholar]
  108. Leff S. E., Rosenfeld M. G., Evans R. M. Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu Rev Biochem. 1986;55:1091–1117. doi: 10.1146/annurev.bi.55.070186.005303. [DOI] [PubMed] [Google Scholar]
  109. Lembeck F., Gamse R. Substance P in peripheral sensory processes. Ciba Found Symp. 1982;(91):35–54. doi: 10.1002/9780470720738.ch4. [DOI] [PubMed] [Google Scholar]
  110. Lentz T. L. A role of cyclic AMP in a neurotrophic process. Nat New Biol. 1972 Aug 2;238(83):154–155. doi: 10.1038/newbio238154a0. [DOI] [PubMed] [Google Scholar]
  111. Lenz H. J., Mortrud M. T., Rivier J. E., Brown M. R. Central nervous system actions of calcitonin gene-related peptide on gastric acid secretion in the rat. Gastroenterology. 1985 Feb;88(2):539–544. doi: 10.1016/0016-5085(85)90518-9. [DOI] [PubMed] [Google Scholar]
  112. Luben R. A., Wong G. L., Cohn D. V. Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts. Endocrinology. 1976 Aug;99(2):526–534. doi: 10.1210/endo-99-2-526. [DOI] [PubMed] [Google Scholar]
  113. Lundberg J. M., Franco-Cereceda A., Hua X., Hökfelt T., Fischer J. A. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol. 1985 Feb 5;108(3):315–319. doi: 10.1016/0014-2999(85)90456-x. [DOI] [PubMed] [Google Scholar]
  114. MacIntyre I., Alevizaki M., Bevis P. J., Zaidi M. Calcitonin and the peptides from the calcitonin gene. Clin Orthop Relat Res. 1987 Apr;(217):45–55. [PubMed] [Google Scholar]
  115. Maier R., Riniker B., Rittel W. Analogues of human calcitonin. I. Influence of modifications in amino acid positions 29 and 31 on hypocalcaemic activity in the rat. FEBS Lett. 1974 Nov 1;48(1):68–71. doi: 10.1016/0014-5793(74)81064-1. [DOI] [PubMed] [Google Scholar]
  116. Malaisse W. J., Lebrun P., Herchuelz A., Sener A., Malaisse-Lagae F. Synergistic effect of a tumor-promoting phorbol ester and a hypoglycemic sulfonylurea upon insulin release. Endocrinology. 1983 Nov;113(5):1870–1877. doi: 10.1210/endo-113-5-1870. [DOI] [PubMed] [Google Scholar]
  117. Maniatis T., Reed R. The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing. Nature. 1987 Feb 19;325(6106):673–678. doi: 10.1038/325673a0. [DOI] [PubMed] [Google Scholar]
  118. Manning M., Przybylski J. P., Olma A., Klis W. A., Kruszynski M., Wo N. C., Pelton G. H., Sawyer W. H. No requirements of cyclic conformation of antagonists in binding to vasopressin receptors. 1987 Oct 29-Nov 4Nature. 329(6142):839–840. doi: 10.1038/329839a0. [DOI] [PubMed] [Google Scholar]
  119. Martin T. J., Robinson C. J., MacIntyre I. The mode of action of thyrocalcitonin. Lancet. 1966 Apr 23;1(7443):900–902. doi: 10.1016/s0140-6736(66)91577-7. [DOI] [PubMed] [Google Scholar]
  120. Marx S. J., Aurbach G. D., Gavin J. R., 3rd, Buell D. W. Calcitonin receptors on cultured human lymphocytes. J Biol Chem. 1974 Nov 10;249(21):6812–6816. [PubMed] [Google Scholar]
  121. Marx S. J., Woodward C. J., Aurbach G. D. Calcitonin receptors of kidney and bone. Science. 1972 Dec 1;178(4064):999–1001. doi: 10.1126/science.178.4064.999. [DOI] [PubMed] [Google Scholar]
  122. Marx S. J., Woodward C., Aurbach G. D., Glossmann H., Keutmann H. T. Renal receptors for calcitonin. Binding and degradation of hormone. J Biol Chem. 1973 Jul 10;248(13):4797–4802. [PubMed] [Google Scholar]
  123. McCulloch J., Uddman R., Kingman T. A., Edvinsson L. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5731–5735. doi: 10.1073/pnas.83.15.5731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. McEwan J., Larkin S., Davies G., Chierchia S., Brown M., Stevenson J., MacIntyre I., Maseri A. Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries. Circulation. 1986 Dec;74(6):1243–1247. doi: 10.1161/01.cir.74.6.1243. [DOI] [PubMed] [Google Scholar]
  125. Michelangeli V. P., Findlay D. M., Moseley J. M., Martin T. J. Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells. J Cyclic Nucleotide Protein Phosphor Res. 1983;9(2):129–141. [PubMed] [Google Scholar]
  126. Milhaud G., Perault A. M., Moukhtar M. S. Etude du mécanisme de l'action hypocalcémiante de la thyrocalcitonine. C R Acad Sci Hebd Seances Acad Sci D. 1965 Jul 19;261(3):813–816. [PubMed] [Google Scholar]
  127. Moran J., Hunziker W., Fischer J. A. Calcitonin and calcium ionophores: cyclic AMP responses in cells of a human lymphoid line. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3984–3988. doi: 10.1073/pnas.75.8.3984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Morikawa T., Munekata E., Sakakibara S., Noda T., Otani M. Synthesis of eel-calcitonin and (asu1,7)-eel-calcitonin: contribution of the disulfide bond to the hormonal activity. Experientia. 1976 Sep 15;32(9):1104–1106. doi: 10.1007/BF01927568. [DOI] [PubMed] [Google Scholar]
  129. Morris H. R., Panico M., Etienne T., Tippins J., Girgis S. I., MacIntyre I. Isolation and characterization of human calcitonin gene-related peptide. Nature. 1984 Apr 19;308(5961):746–748. doi: 10.1038/308746a0. [DOI] [PubMed] [Google Scholar]
  130. Moseley J. M., Findlay D. M., Gorman J. J., Michelangeli V. P., Martin T. J. The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation. Biochem J. 1983 Jun 15;212(3):609–616. doi: 10.1042/bj2120609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Moseley J. M., Findlay D. M., Martin T. J., Gorman J. J. Covalent cross-linking of a photoactive derivative of calcitonin to human breast cancer cell receptors. J Biol Chem. 1982 May 25;257(10):5846–5851. [PubMed] [Google Scholar]
  132. Murdoch G. H., Rosenfeld M. G. Eukaryotic transcriptional regulation and chromatin-associated protein phosphorylation by cyclic AMP. Science. 1982 Dec 24;218(4579):1315–1317. doi: 10.1126/science.6293056. [DOI] [PubMed] [Google Scholar]
  133. Muszynski M., Birnbaum R. S., Roos B. A. Glucocorticoids stimulate the production of preprocalcitonin-derived secretory peptides by a rat medullary thyroid carcinoma cell line. J Biol Chem. 1983 Oct 10;258(19):11678–11683. [PubMed] [Google Scholar]
  134. Nakagawa T., Mabry M., de Bustros A., Ihle J. N., Nelkin B. D., Baylin S. B. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5923–5927. doi: 10.1073/pnas.84.16.5923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Nakhla A. M., Nandi Majumdar A. P. Calcitonin-mediated changes in plasma tryptophan and brain 5-hydroxytryptamine and acetylcholinesterase activity in rats. Biochem J. 1978 Feb 15;170(2):445–448. doi: 10.1042/bj1700445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Neher R., Riniker B., Maier R., Byfield P. G., Gudmundsson T. V., MacIntyre I. Human calcitonin. Nature. 1968 Dec 7;220(5171):984–986. doi: 10.1038/220984a0. [DOI] [PubMed] [Google Scholar]
  137. Nelkin B. D., Rosenfeld K. I., de Bustros A., Leong S. S., Roos B. A., Baylin S. B. Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide. Biochem Biophys Res Commun. 1984 Sep 17;123(2):648–655. doi: 10.1016/0006-291x(84)90278-x. [DOI] [PubMed] [Google Scholar]
  138. New H. V., Mudge A. W. Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis. 1986 Oct 30-Nov 5Nature. 323(6091):809–811. doi: 10.1038/323809a0. [DOI] [PubMed] [Google Scholar]
  139. Ng K. W., Livesey S. A., Larkins R. G., Martin T. J. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells. Cancer Res. 1983 Feb;43(2):794–800. [PubMed] [Google Scholar]
  140. Nguyen K. Q., Sills M. A., Jacobowitz D. M. Cardiovascular effects produced by microinjection of calcitonin gene-related peptide into the rat central amygdaloid nucleus. Peptides. 1986 Mar-Apr;7(2):337–339. doi: 10.1016/0196-9781(86)90233-0. [DOI] [PubMed] [Google Scholar]
  141. Niall H. D., Keutmann H. T., Copp D. H., Potts J. T., Jr Amino acid sequence of salmon ultimobranchial calcitonin. Proc Natl Acad Sci U S A. 1969 Oct;64(2):771–778. doi: 10.1073/pnas.64.2.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Nicholson G. C., Moseley J. M., Sexton P. M., Mendelsohn F. A., Martin T. J. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest. 1986 Aug;78(2):355–360. doi: 10.1172/JCI112584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Noda M., Ko M., Ogura A., Liu D. G., Amano T., Takano T., Ikawa Y. Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature. 1985 Nov 7;318(6041):73–75. doi: 10.1038/318073a0. [DOI] [PubMed] [Google Scholar]
  144. Ohhashi T., Jacobowitz D. M. Effect of calcitonin gene-related peptide on the neuroeffector mechanism of sympathetic nerve terminals in rat vas deferens. Peptides. 1985 Sep-Oct;6(5):987–991. doi: 10.1016/0196-9781(85)90332-8. [DOI] [PubMed] [Google Scholar]
  145. Orlowski R. C., Epand R. M., Stafford A. R. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure. Eur J Biochem. 1987 Jan 15;162(2):399–402. doi: 10.1111/j.1432-1033.1987.tb10615.x. [DOI] [PubMed] [Google Scholar]
  146. Otani M., Yamauchi H., Meguro T., Kitazawa S., Watanabe S., Orimo H. Isolation and characterization of calcitonin from pericardium and esophagus of eel. J Biochem. 1976 Feb;79(2):345–352. doi: 10.1093/oxfordjournals.jbchem.a131077. [DOI] [PubMed] [Google Scholar]
  147. Padgett R. A., Grabowski P. J., Konarska M. M., Seiler S., Sharp P. A. Splicing of messenger RNA precursors. Annu Rev Biochem. 1986;55:1119–1150. doi: 10.1146/annurev.bi.55.070186.005351. [DOI] [PubMed] [Google Scholar]
  148. Pecile A., Ferri S., Braga P. C., Olgiati V. R. Effects of intracerebroventricular calcitonin in the conscious rabbit. Experientia. 1975 Mar 15;31(3):332–333. doi: 10.1007/BF01922569. [DOI] [PubMed] [Google Scholar]
  149. Peterfreund R. A., Vale W. W. Phorbol diesters stimulate somatostatin secretion from cultured brain cells. Endocrinology. 1983 Jul;113(1):200–208. doi: 10.1210/endo-113-1-200. [DOI] [PubMed] [Google Scholar]
  150. Petermann J. B., Born W., Chang J. Y., Fischer J. A. Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord. J Biol Chem. 1987 Jan 15;262(2):542–545. [PubMed] [Google Scholar]
  151. Platt T. Transcription termination and the regulation of gene expression. Annu Rev Biochem. 1986;55:339–372. doi: 10.1146/annurev.bi.55.070186.002011. [DOI] [PubMed] [Google Scholar]
  152. Potts J. T., Jr, Niall H. D., Keutmann H. T., Brewer H. B., Jr, Deftos L. J. The amino acid sequence of porcine thyrocalcitonin. Proc Natl Acad Sci U S A. 1968 Apr;59(4):1321–1328. doi: 10.1073/pnas.59.4.1321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Proudfoot N. J., Brownlee G. G. 3' non-coding region sequences in eukaryotic messenger RNA. Nature. 1976 Sep 16;263(5574):211–214. doi: 10.1038/263211a0. [DOI] [PubMed] [Google Scholar]
  154. Rasmussen H., Wong M., Bikle D., Goodman D. B. Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest. 1972 Sep;51(9):2502–2504. doi: 10.1172/JCI107065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Raulais D., Hagaman J., Ontjes D. A., Lundblad R. L., Kingdon H. S. The complete amino-acid sequence of rat thyrocalcitonin. Eur J Biochem. 1976 May 1;64(2):607–611. doi: 10.1111/j.1432-1033.1976.tb10340.x. [DOI] [PubMed] [Google Scholar]
  156. Riley J. H., Edbrooke M. R., Craig R. K. Ectopic synthesis of high-Mr calcitonin by the BEN lung carcinoma cell line reflects aberrant proteolytic processing. FEBS Lett. 1986 Mar 17;198(1):71–79. doi: 10.1016/0014-5793(86)81187-5. [DOI] [PubMed] [Google Scholar]
  157. Riniker B., Neher R., Maier R., Kahnt F. W., Byfield P. G., Gudmundsson T. V., Galante L., MacIntyre I. Menschliches Calcitonin. I. Isolierung und Charakterisierung. Helv Chim Acta. 1968 Oct 31;51(7):1738–1742. doi: 10.1002/hlca.19680510731. [DOI] [PubMed] [Google Scholar]
  158. Rittel W., Maier R., Brugger M., Kamber B., Riniker B., Sieber P. Struktur-Wirkungsbeziehungen beim menschlichen Calcitonin. III. Die biologische Aktivität verkürzter oder an den Kettenenden modifizierter, synthetischer Analoger. Experientia. 1976 Feb 15;32(2):246–248. doi: 10.1007/BF01937791. [DOI] [PubMed] [Google Scholar]
  159. Rizzo A. J., Goltzman D. Calcitonin receptors in the central nervous system of the rat. Endocrinology. 1981 May;108(5):1672–1677. doi: 10.1210/endo-108-5-1672. [DOI] [PubMed] [Google Scholar]
  160. Robinson C. J., Martin T. J., Matthews E. W., MacIntyre I. Mode of action of thyrocalcitonin. J Endocrinol. 1967 Sep;39(1):71–79. doi: 10.1677/joe.0.0390071. [DOI] [PubMed] [Google Scholar]
  161. Rodrigo J., Polak J. M., Fernandez L., Ghatei M. A., Mulderry P., Bloom S. R. Calcitonin gene-related peptide immunoreactive sensory and motor nerves of the rat, cat, and monkey esophagus. Gastroenterology. 1985 Feb;88(2):444–451. doi: 10.1016/0016-5085(85)90505-0. [DOI] [PubMed] [Google Scholar]
  162. Roos B. A., Fischer J. A., Pignat W., Alander C. B., Raisz L. G. Evaluation of the in vivo and in vitro calcium-regulating actions of noncalcitonin peptides produced via calcitonin gene expression. Endocrinology. 1986 Jan;118(1):46–51. doi: 10.1210/endo-118-1-46. [DOI] [PubMed] [Google Scholar]
  163. Rosenfeld M. G., Amara S. G., Evans R. M. Alternative RNA processing: determining neuronal phenotype. Science. 1984 Sep 21;225(4668):1315–1320. doi: 10.1126/science.6089345. [DOI] [PubMed] [Google Scholar]
  164. Rosenfeld M. G., Amara S. G., Roos B. A., Ong E. S., Evans R. M. Altered expression of the calcitonin gene associated with RNA polymorphism. Nature. 1981 Mar 5;290(5801):63–65. doi: 10.1038/290063a0. [DOI] [PubMed] [Google Scholar]
  165. Rosenfeld M. G., Lin C. R., Amara S. G., Stolarsky L., Roos B. A., Ong E. S., Evans R. M. Calcitonin mRNA polymorphism: peptide switching associated with alternative RNA splicing events. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1717–1721. doi: 10.1073/pnas.79.6.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Rosenfeld M. G., Mermod J. J., Amara S. G., Swanson L. W., Sawchenko P. E., Rivier J., Vale W. W., Evans R. M. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 1983 Jul 14;304(5922):129–135. doi: 10.1038/304129a0. [DOI] [PubMed] [Google Scholar]
  167. Saad M. F., Ordonez N. G., Guido J. J., Samaan N. A. The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid. J Clin Endocrinol Metab. 1984 Nov;59(5):850–856. doi: 10.1210/jcem-59-5-850. [DOI] [PubMed] [Google Scholar]
  168. Sabate M. I., Stolarsky L. S., Polak J. M., Bloom S. R., Varndell I. M., Ghatei M. A., Evans R. M., Rosenfeld M. G. Regulation of neuroendocrine gene expression by alternative RNA processing. Colocalization of calcitonin and calcitonin gene-related peptide in thyroid C-cells. J Biol Chem. 1985 Mar 10;260(5):2589–2592. [PubMed] [Google Scholar]
  169. Schwartz K. E., Orlowski R. C., Marcus R. des-Ser2 salmon calcitonin: a biologically potent synthetic analog. Endocrinology. 1981 Mar;108(3):831–835. doi: 10.1210/endo-108-3-831. [DOI] [PubMed] [Google Scholar]
  170. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. 1987 Oct 29-Nov 4Nature. 329(6142):840–842. doi: 10.1038/329840a0. [DOI] [PubMed] [Google Scholar]
  171. Seed B., Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci U S A. 1987 May;84(10):3365–3369. doi: 10.1073/pnas.84.10.3365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Segond N., Legendre B., Tahri E. H., Besnard P., Jullienne A., Moukhtar M. S., Garel J. M. Increased level of calcitonin mRNA after 1,25-dihydroxyvitamin D3 injection in the rat. FEBS Lett. 1985 May 20;184(2):268–272. doi: 10.1016/0014-5793(85)80620-7. [DOI] [PubMed] [Google Scholar]
  173. Seifert H., Sawchenko P., Chesnut J., Rivier J., Vale W., Pandol S. J. Receptor for calcitonin gene-related peptide: binding to exocrine pancreas mediates biological actions. Am J Physiol. 1985 Jul;249(1 Pt 1):G147–G151. doi: 10.1152/ajpgi.1985.249.1.G147. [DOI] [PubMed] [Google Scholar]
  174. Sigrist S., Franco-Cereceda A., Muff R., Henke H., Lundberg J. M., Fischer J. A. Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology. 1986 Jul;119(1):381–389. doi: 10.1210/endo-119-1-381. [DOI] [PubMed] [Google Scholar]
  175. Sikri K. L., Varndell I. M., Hamid Q. A., Wilson B. S., Kameya T., Ponder B. A., Lloyd R. V., Bloom S. R., Polak J. M. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers. Cancer. 1985 Nov 15;56(10):2481–2491. doi: 10.1002/1097-0142(19851115)56:10<2481::aid-cncr2820561026>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  176. Skofitsch G., Jacobowitz D. M. Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides. 1985 Jul-Aug;6(4):747–754. doi: 10.1016/0196-9781(85)90179-2. [DOI] [PubMed] [Google Scholar]
  177. Solnick D. Alternative splicing caused by RNA secondary structure. Cell. 1985 Dec;43(3 Pt 2):667–676. doi: 10.1016/0092-8674(85)90239-9. [DOI] [PubMed] [Google Scholar]
  178. Solnick D., Lee S. I. Amount of RNA secondary structure required to induce an alternative splice. Mol Cell Biol. 1987 Sep;7(9):3194–3198. doi: 10.1128/mcb.7.9.3194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Steenbergh P. H., Höppener J. W., Zandberg J., Lips C. J., Jansz H. S. A second human calcitonin/CGRP gene. FEBS Lett. 1985 Apr 22;183(2):403–407. doi: 10.1016/0014-5793(85)80820-6. [DOI] [PubMed] [Google Scholar]
  180. Steenbergh P. H., Höppener J. W., Zandberg J., Visser A., Lips C. J., Jansz H. S. Structure and expression of the human calcitonin/CGRP genes. FEBS Lett. 1986 Dec 1;209(1):97–103. doi: 10.1016/0014-5793(86)81091-2. [DOI] [PubMed] [Google Scholar]
  181. Stevenson J. C., Abeyasekera G., Hillyard C. J., Phang K. G., MacIntyre I., Campbell S., Townsend P. T., Young O., Whitehead M. I. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet. 1981 Mar 28;1(8222):693–695. doi: 10.1016/s0140-6736(81)91973-5. [DOI] [PubMed] [Google Scholar]
  182. Supowit S. C., Potter E., Evans R. M., Rosenfeld M. G. Polypeptide hormone regulation of gene transcription: specific 5' genomic sequences are required for epidermal growth factor and phorbol ester regulation of prolactin gene expression. Proc Natl Acad Sci U S A. 1984 May;81(10):2975–2979. doi: 10.1073/pnas.81.10.2975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Takami K., Hashimoto K., Uchida S., Tohyama M., Yoshida H. Effect of calcitonin gene-related peptide on the cyclic AMP level of isolated mouse diaphragm. Jpn J Pharmacol. 1986 Nov;42(3):345–350. doi: 10.1254/jjp.42.345. [DOI] [PubMed] [Google Scholar]
  184. Takami K., Kawai Y., Shiosaka S., Lee Y., Girgis S., Hillyard C. J., MacIntyre I., Emson P. C., Tohyama M. Immunohistochemical evidence for the coexistence of calcitonin gene-related peptide- and choline acetyltransferase-like immunoreactivity in neurons of the rat hypoglossal, facial and ambiguus nuclei. Brain Res. 1985 Mar 4;328(2):386–389. doi: 10.1016/0006-8993(85)91055-8. [DOI] [PubMed] [Google Scholar]
  185. Tashjian A. H., Jr, Wright D. R., Ivey J. L., Pont A. Calcitonin binding sites in bone: relationships to biological response and "escape". Recent Prog Horm Res. 1978;34:285–334. doi: 10.1016/b978-0-12-571134-0.50012-0. [DOI] [PubMed] [Google Scholar]
  186. The effect of thyrocalcitonin on blood-bone calcium equilibrium in the perfused tibia of the cat. J Physiol. 1967 Jul;191(2):393–405. doi: 10.1113/jphysiol.1967.sp008257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Tippins J. R., Di Marzo V., Panico M., Morris H. R., MacIntyre I. Investigation of the structure/activity relationship of human calcitonin gene-related peptide (CGRP). Biochem Biophys Res Commun. 1986 Feb 13;134(3):1306–1311. doi: 10.1016/0006-291x(86)90392-x. [DOI] [PubMed] [Google Scholar]
  188. Tippins J. R., Morris H. R., Panico M., Etienne T., Bevis P., Girgis S., MacIntyre I., Azria M., Attinger M. The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP). Neuropeptides. 1984 Sep;4(5):425–434. doi: 10.1016/0143-4179(84)90118-5. [DOI] [PubMed] [Google Scholar]
  189. Trump D. L., Mendelsohn G., Baylin S. B. Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma. N Engl J Med. 1979 Aug 2;301(5):253–255. doi: 10.1056/NEJM197908023010507. [DOI] [PubMed] [Google Scholar]
  190. Tschopp F. A., Henke H., Petermann J. B., Tobler P. H., Janzer R., Hökfelt T., Lundberg J. M., Cuello C., Fischer J. A. Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc Natl Acad Sci U S A. 1985 Jan;82(1):248–252. doi: 10.1073/pnas.82.1.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Twery M. J., Moss R. L. Calcitonin and calcitonin gene-related peptide alter the excitability of neurons in rat forebrain. Peptides. 1985 May-Jun;6(3):373–378. doi: 10.1016/0196-9781(85)90098-1. [DOI] [PubMed] [Google Scholar]
  192. Vale W., River C. Substances modulating the secretion of ACTH by cultured anterior pituitary cells. Fed Proc. 1977 Jul;36(8):2094–2099. [PubMed] [Google Scholar]
  193. Virji M. A., Steffes M. W., Estensen R. D. Phorbol myristate acetate: effect of a tumor promoter on insulin release from isolated rat islets of Langerhans. Endocrinology. 1978 Mar;102(3):706–711. doi: 10.1210/endo-102-3-706. [DOI] [PubMed] [Google Scholar]
  194. Walker J. W., Somlyo A. V., Goldman Y. E., Somlyo A. P., Trentham D. R. Kinetics of smooth and skeletal muscle activation by laser pulse photolysis of caged inositol 1,4,5-trisphosphate. Nature. 1987 May 21;327(6119):249–252. doi: 10.1038/327249a0. [DOI] [PubMed] [Google Scholar]
  195. Wanaka A., Matsuyama T., Yoneda S., Kamada T., Emson P. C., Hillard J., Girgis S. J., Machintyre I., Tohyama M. Distribution patterns of calcitonin gene-related peptide-containing fibers in the wall of the three different arteries: an immunohistochemical study. Cell Mol Biol. 1987;33(2):201–209. [PubMed] [Google Scholar]
  196. Warshawsky H., Goltzman D., Rouleau M. F., Bergeron J. J. Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J Cell Biol. 1980 Jun;85(3):682–694. doi: 10.1083/jcb.85.3.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Wickner W. T., Lodish H. F. Multiple mechanisms of protein insertion into and across membranes. Science. 1985 Oct 25;230(4724):400–407. doi: 10.1126/science.4048938. [DOI] [PubMed] [Google Scholar]
  198. Williams T. J. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol. 1982 Nov;77(3):505–509. doi: 10.1111/j.1476-5381.1982.tb09324.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Wimalawansa S. J., Emson P. C., MacIntyre I. Regional distribution of calcitonin gene-related peptide and its specific binding sites in rats with particular reference to the nervous system. Neuroendocrinology. 1987 Aug;46(2):131–136. doi: 10.1159/000124809. [DOI] [PubMed] [Google Scholar]
  200. Wohlwend A., Malmström K., Henke H., Murer H., Vassalli J. D., Fischer J. A. Calcitonin and calcitonin gene-related peptide interact with the same receptor in cultured LLC-PK1 kidney cells. Biochem Biophys Res Commun. 1985 Sep 16;131(2):537–542. doi: 10.1016/0006-291x(85)91269-0. [DOI] [PubMed] [Google Scholar]
  201. Wrann M. M., Fox C. F. Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line. J Biol Chem. 1979 Sep 10;254(17):8083–8086. [PubMed] [Google Scholar]
  202. Yamada M., Matsumoto T., Su K. W., Ogata E. Inhibition by prostaglandin E2 of renal effects of calcitonin in rats. Endocrinology. 1985 Feb;116(2):693–697. doi: 10.1210/endo-116-2-693. [DOI] [PubMed] [Google Scholar]
  203. Zaidi M., Bevis P. J., Abeyasekera G., Girgis S. I., Wimalawansa S. J., Morris H. R., MacIntyre I. The origin of circulating calcitonin gene-related peptide in the rat. J Endocrinol. 1986 Jul;110(1):185–190. doi: 10.1677/joe.0.1100185. [DOI] [PubMed] [Google Scholar]
  204. Zaidi M., Bevis P. J., Girgis S. I., Lynch C., Stevenson J. C., MacIntyre I. Circulating CGRP comes from the perivascular nerves. Eur J Pharmacol. 1985 Nov 5;117(2):283–284. doi: 10.1016/0014-2999(85)90616-8. [DOI] [PubMed] [Google Scholar]
  205. Zaidi M., Breimer L. H., MacIntyre I. Biology of peptides from the calcitonin genes. Q J Exp Physiol. 1987 Oct;72(4):371–408. doi: 10.1113/expphysiol.1987.sp003084. [DOI] [PubMed] [Google Scholar]
  206. Zaidi M., Chambers T. J., Bevis P. J., Beacham J. L., Gaines Das R. E., MacIntyre I. Effects of peptides from the calcitonin genes on bone and bone cells. Q J Exp Physiol. 1988 Jul;73(4):471–485. doi: 10.1113/expphysiol.1988.sp003168. [DOI] [PubMed] [Google Scholar]
  207. Zaidi M., Chambers T. J., Gaines Das R. E., Morris H. R., MacIntyre I. A direct action of human calcitonin gene-related peptide on isolated osteoclasts. J Endocrinol. 1987 Dec;115(3):511–518. doi: 10.1677/joe.0.1150511. [DOI] [PubMed] [Google Scholar]
  208. Zaidi M., Fuller K., Bevis P. J., GainesDas R. E., Chambers T. J., MacIntyre I. Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study. Calcif Tissue Int. 1987 Mar;40(3):149–154. doi: 10.1007/BF02555699. [DOI] [PubMed] [Google Scholar]
  209. Zajac J. D., Martin T. J., Hudson P., Niall H., Jacobs J. W. Biosynthesis of calcitonin by human lung cancer cells. Endocrinology. 1985 Feb;116(2):749–755. doi: 10.1210/endo-116-2-749. [DOI] [PubMed] [Google Scholar]
  210. Zalups R. K., Knox F. G. Calcitonin decreases the renal tubular capacity for phosphate reabsorption. Am J Physiol. 1983 Sep;245(3):F345–F348. doi: 10.1152/ajprenal.1983.245.3.F345. [DOI] [PubMed] [Google Scholar]
  211. Zhuang Y., Leung H., Weiner A. M. The natural 5' splice site of simian virus 40 large T antigen can be improved by increasing the base complementarity to U1 RNA. Mol Cell Biol. 1987 Aug;7(8):3018–3020. doi: 10.1128/mcb.7.8.3018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Zhuang Y., Leung H., Weiner A. M. The natural 5' splice site of simian virus 40 large T antigen can be improved by increasing the base complementarity to U1 RNA. Mol Cell Biol. 1987 Aug;7(8):3018–3020. doi: 10.1128/mcb.7.8.3018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. de Bustros A., Baylin S. B., Berger C. L., Roos B. A., Leong S. S., Nelkin B. D. Phorbol esters increase calcitonin gene transcription and decrease c-myc mRNA levels in cultured human medullary thyroid carcinoma. J Biol Chem. 1985 Jan 10;260(1):98–104. [PubMed] [Google Scholar]
  214. deBustros A., Baylin S. B., Levine M. A., Nelkin B. D. Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma. J Biol Chem. 1986 Jun 15;261(17):8036–8041. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES